Regulus Therapeutics Inc. - Common Stock, par value $0.001 per share (RGLS)

Historical Holders from Q2 2022 to Q3 2025

Symbol
RGLS on Nasdaq
CUSIP
75915K309
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
66.5M
All holders as of September 30, 2025
Q3 2025
Number of holders
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Regulus Therapeutics Inc. - Common Stock, par value $0.001 per share (RGLS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Vivo Opportunity Fund Holdings, L.P. 3.9% $4.64M 2.7M Vivo Opportunity Fund Holdings, L.P. Mar 31, 2025
Point72 Asset Management, L.P. 0.3% -93.3% $1.9M -$29M 241K -93.9% Point72 Asset Management, L.P. Jun 30, 2025

Institutional Holders of Regulus Therapeutics Inc. - Common Stock, par value $0.001 per share (RGLS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 0
2025 Q2 0 $0 -$105M $8.16 0
2025 Q1 53.6M $105M +$3.11M $1.75 74
2024 Q4 53.5M $84.5M -$5.13M $1.58 68
2024 Q3 56.7M $89.1M +$3.28M $1.57 71
2024 Q2 54.8M $97.9M +$13.5M $1.79 63
2024 Q1 45.6M $129M +$103M $2.88 44
2023 Q4 9.17M $11.7M +$40.1K $1.28 24
2023 Q3 8.96M $12.3M +$1M $1.37 23
2023 Q2 8.23M $12.1M +$2.41M $1.47 22
2023 Q1 6.6M $5.59M -$77.4K $0.85 23
2022 Q4 6.67M $9.14M -$4.97K $1.37 22
2022 Q3 6.67M $11.3M +$3.42M $1.70 21
2022 Q2 4.62M $9.56M +$9.56M $2.06 22